Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

Clinical trial NCT03587844 · RECRUITING

Trial details

NCT number: NCT03587844
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mycosis Fungoides Lymphomatoid Papulosis Sezary Syndrome

Start date: 2018-07-03
Primary completion: 2027-07-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.